Fourier Intelligence, a maker of robots used for medical rehabilitation, has completed a Series B+ funding round, collecting tens of millions of yuan from sole investor Qianhai Fund of Funds, a Shenzhen-based equity financing firm, according to a Wednesday press release from the firm.
The company has not disclosed the exact sum of new money raised, but said that proceeds from this round plus a Series B round in July 2019 total nearly RMB 100 million (USD 14.1 million).
Alex Gu, founder and CEO of Fourier Intelligence, said the new funding will boost the company’s capability to deliver innovative, cost-efficient products and services to clients.
The company develops robots that assist patients recover after mobility-related injuries. Their products include the ArmMotus, for arm rehabilitation, WristMotus for wrists, and AnkleMotus for ankles.
Gu said major hospitals including the Ruijin and Huashan hospitals in Shanghai have bought such robots.
This article is part of KrASIA’s “China Brief” section, where KrASIA’s reporters will provide quick daily updates about the tech ecosystem in China.
